Javier Casellas MD PID PhD’s Post

View profile for Javier Casellas MD PID PhD, graphic

+9,290 followers worldwide. IQVIA Global Medical Director ARIDV (Allergy, Respiratory, Infectious Diseases and Vaccines)- Independent Vaccine Expert Consultant - Career Mentor- Vaccines Beat Co Chief Editor

https://lnkd.in/eEQUpNKQ What is added by this report? The increasing number of reported suspected clade I mpox cases in the Democratic Republic of the Congo (DRC) poses a global threat for potential spread. No clade I cases have been reported in countries without endemic transmission. CDC is supporting DRC’s response and containment efforts and ensuring U.S. preparedness by increasing awareness and surveillance, expanding clade I diagnostic testing capacity, and communicating guidance. What are the implications for public health practice? U.S. clinicians and public health practitioners should be alert for possible cases in travelers from DRC and request clade-specific testing. Appropriate medical treatment is critical given the potential for severe illness, and contact tracing and containment strategies, including isolation, behavior modification and vaccination, will be important to prevent spread if any U.S. clade I mpox cases occur.

U.S. Preparedness and Response to Increasing Clade ...

U.S. Preparedness and Response to Increasing Clade ...

cdc.gov

To view or add a comment, sign in

Explore topics